AI Multi-Cancer Screening Debut at ASMS 2026

Seer Inc. and Korea University presented a new AI-powered proteomics platform at the ASMS 2026 conference ^[1]. The technology analyzes thousands of proteins within blood samples to identify signs of multiple cancers ^[1]. This approach aims to provide highly sensitive screening for large-scale population health initiatives ^[1].

The platform utilizes advanced artificial intelligence to process complex biological data from protein samples ^[1]. Researchers designed the system to be scalable, allowing for widespread use in public health across various regions ^[1]. This collaboration highlights the growing role of machine learning in early disease detection ^[1].